Publications

5539 Results

Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of Southwest Oncology Group study 8894

Authors
TM Beer;CM Tangen;LB Bland;IM Thompson;ED Crawford
Journal / Conference
Journal of Urology 171(6, part 1 of 2):2213-2217
Year
2004
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Mutant DNA in plasma of lung cancer patients; potential for monitoring response to therapy

Authors
T Kimura;WS Holland;T Kawaguchi;SK Williamson;K Chansky;JJ Crowley;JH Doroshow;HJ Lenz;DR Gandara;PH Gumerlock
Journal / Conference
Annals of the New York Academy of Sciences 1022:55-60
Year
2004
Research Committee(s)
Lung
Study Number(s)
S0003

First international conference on chemoprevention of prostate cancer

Authors
IM Thompson;D Albanes;JW Basler;ED Crawford;LJ Denis;B Djavan;N Fleshner;TL Johnson-Pais;EA Klein;AR Kristal;MS Lucia;HL Parnes;GA Piazza;EA Platz;BH Pollock;DK Price;JK Reichardt;CM Tangen;AW Tolcher;MC McMann
Journal / Conference
Journal of Urology 171:S3-S4
Year
2004
Research Committee(s)
Cancer Control and Prevention and Epidemiology
Study Number(s)
S0000, SWOG-9217

Accrual patterns of the Southwest Oncology Group (SWOG) by sex, race/ethnicity, and age: updated adn expanded analyses

Authors
JM Unger;JJ Crowley;CA Coltman;LF Hutchins;S Martino;JS Macdonald;DR Gandara;ED Crawford;RB Livingston;KS Albain
Journal / Conference
Proc of the American Society of Clinical Oncology 23:520(#6014)
Year
2004

Prognostic value of anemia in untreated metastatic prostate cancer: a multivariate analysis of SWOG 8894

Authors
LB Bland;CM Tangen;IM Thompson;ED Crawford;TM Beer
Journal / Conference
Proc of the American Society of Clinical Oncology 23:399 (#4574)
Year
2004
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Fludarabine and cyclophosphamide produces a higher complete response rate and more durable remissions than fludarabine in patients with previously untreated CLL: Intergroup trial E2997

Authors
IW Flinn;E Kumm;MR Grever;D Neuberg;GW Dewald;JM Bennett;EM Paietta;FR Appelbaum;RA Larson;MA Hussein;DF Moore Jr;MS Tallman
Journal / Conference
Blood 104(11): #475
Year
2004
Research Committee(s)
Leukemia
Study Number(s)
E2997

Enhancing well-being during breast cancer recurrence: preliminary findings from a phase III study

Authors
CC Gotay;CM Moinpour;CS Jiang;DP Ankerst;D Coleman;S Martino;B Taylor;J Bearden;S Dakhil;H Gross;DS Albain
Journal / Conference
Breast Cancer Research and Treatment 88(Suppl 1):S140 (#3080)
Year
2004
Research Committee(s)
Breast
Study Number(s)
S9632, S9832

Under-representation of elderly patients in cancer clinical trials: causes and remedial strategies

Authors
JM Unger;LF Hutchins;KS Albain
Journal / Conference
Comprehensive Geriatric Oncology 2nd ed. Taylor & Francis; 2004, Chapter 22
Year
2004

The prostate cancer prevention trial: the association of study site and participant adherence interventions to the study site end-of-study biopsy rates

Authors
S Carlin;P Goodman;C Moinpour;C Tangen
Journal / Conference
Clinical Trials 1 (Suppl 1):P45
Year
2004
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Extreme regression: a statistical technique for finding good or poor prognostic groups, illustrated using myeloma patient data from Intergroup trial S9321

Authors
JJ Crowley;J McCoy;M LeBlanc;B Barlogie
Journal / Conference
Blood 104(11): #5202
Year
2004
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9321